Table of Contents
PharmSights
| Effects of Histone Deacetylase Inhibitors on Modulating H3K4 Methylation Marks – A Novel Cross-Talk Mechanism between Histone-Modifying Enzymes |
Abstract PDF |
| Po-Hsien Huang, Christoph Plass, Ching-Shih Chen |
39-43 |
| Functional Roles of Endothelin ETB Receptor in the Vascular Disease and Its Sex Difference |
Abstract PDF |
| Kento Kitada, Mamoru Ohkita, Yasuo Matsumura |
45-52 |
| Bladder Selectivity of Imidafenacin, a Novel Antimuscarinic Agent Developed to Treat Overactive Bladder |
Abstract PDF |
| Shizuo Yamada, Akira Yoshida, Masaki Ogoda, Yusuke Fuchihata, Shiori Kuraoka, Hideo Tsukada, Tsuyoshi Anraku |
53-58 |
| Precise Synchrony by Mutual Inhibition: Experiments Vindicate Theory |
Abstract PDF |
| Hang Hu, Yunyong Ma, Ariel Agmon |
59-65 |
| Novel Insights into Beneficial Consequences of Statins in Sepsis: Anti-inflammatory and Anti-apoptotic Mechanisms |
Abstract PDF |
| Kengo Tomita, Ken-ichi Takano, Hiroki Yokoo, Yuichi Hattori |
67-74 |
FDA Corner
| FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor |
Abstract PDF |
| |
75 |
| FDA Approves Erwinaze to Treat a Form of Leukemia |
Abstract PDF |
| |
75-76 |
| FDA Approves Cialis to Treat Benign Prostatic Hyperplasia |
Abstract PDF |
| |
76 |
| FDA Approves Remicade to Treat Ulcerative Colitis in Children 6 Years and Older |
Abstract PDF |
| |
76-77 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.
